Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 10/20 | 0.71 |
| ▸ | MMP9 | P14780 | 9/20 | 0.71 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | MMP3 | P08254 | 2/20 | 0.64 |
| ▸ | MMP13 | P45452 | 2/20 | 0.64 |
| ▸ | MMP1 | P03956 | 1/20 | 0.64 |
| ▸ | MMP7 | P09237 | 1/20 | 0.64 |
| ▸ | CTSL | P07711 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL433897 | 1.00 | MMP2 (0.71) | MMP2MMP9ADAMTS4TDP1ADAMTS5 | |
| SCHEMBL3856155 | 0.96 | MMP2 (0.73) | MMP2MMP9ADAMTS4TDP1ADAMTS5 | |
| Chloromethane SCHEMBL7649372 | 0.95 | MMP2 (0.75) | MMP2MMP9ADAMTS4TDP1ADAMTS5 | |
| SCHEMBL1203540 | 0.95 | MMP2 (0.79) | MMP2MMP9ADAMTS4TDP1ADAMTS5 | |
| SCHEMBL697477 | 0.95 | MMP2 (0.79) | MMP2MMP9ADAMTS4TDP1ADAMTS5 | |
| SCHEMBL697476 | 0.95 | MMP2 (0.79) | MMP2MMP9ADAMTS4TDP1ADAMTS5 | |
| Hydrochloric Acid SCHEMBL11133046 | 0.93 | MMP2 (0.77) | MMP2MMP9ADAMTS4TDP1ADAMTS5 | |
| Hydrochloric Acid SCHEMBL3839410 | 0.93 | MMP2 (0.77) | MMP2MMP9ADAMTS4TDP1ADAMTS5 | |
| SCHEMBL8965755 | 0.93 | MMP9 (0.69) | MMP2MMP9ADAMTS4TDP1ADAMTS5 | |
| Hydrochloric Acid SCHEMBL28872216 | 0.92 | MMP2 (0.75) | MMP2MMP9ADAMTS4TDP1ADAMTS5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0720657-B1 | BIOLOGICALLY RELEVANT METHODS FOR THE RAPID DETERMINATION OF STERILITY | 3M INNOVATIVE PROPERTIES CO (US) | 2007-08-15 | — | — | EP | claimed |
| CN-117858728-A | Chelating compounds for the treatment of substance use disorders and uses thereof | 可利尔科学公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-116390748-A | Compositions for preventing and treating influenza infection and methods of use thereof | 佐治亚大学研究基金会股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| WO-2023106811-A1 | ANTIVIRAL COMPOSITION COMPRISING COTTONSEED EXTRACT, AND PREPARATION METHOD THEREFOR | 전남대학교산학협력단 | 2023-06-15 | — | — | WO | disclosed |
| CN-112195148-B | Serum-free suspension-adapted MDCK cell and application thereof in preparation of influenza virus vaccine | 上海生物制品研究所有限责任公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-112195148-A | Serum-free suspension-adapted MDCK cell and application thereof in preparation of influenza virus vaccine | 上海生物制品研究所有限责任公司 | 2021-01-08 | — | — | CN | disclosed |
| CN-107530368-A | Anticancer composition and use thereof | 高雄医学大学 | 2018-01-02 | — | — | CN | disclosed |
| EP-3047274-A2 | PSA ENZYMATIC ACTIVITY: A NEW BIOMARKER FOR ASSESSING PROSTATE CANCER AGGRESSIVENESS | Ohmx Corporation (US) | 2016-07-27 | — | — | EP | disclosed |
| WO-2015042493-A2 | PSA ENZYMATIC ACTIVITY: A NEW BIOMARKER FOR ASSESSING PROSTATE CANCER AGGRESSIVENESS | OHMX CORPORATION (US) | 2015-03-26 | — | — | WO | disclosed |
| US-20140322740-A1 | PSA PEPTIDASE ACTIVITY (PPA) AS A PROSTATE CANCER BIOMARKER | NORTHWESTERN UNIVERSITY, AN ILLINOIS NOT FOR PROFIT CORPORATION (US) | 2014-10-30 | — | — | US | disclosed |
| WO-1997028185-A1 | ANTI-MICROBIAL PROTEIN | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (as a participant in the COOPERATIVE RESEARCH CENTRE FOR PLANT PATHOLOGY) (AU) | 1997-08-07 | — | — | WO | disclosed |
| US-5616485-A | GENETIC ENGINEERING | CANGENE CORPORATION (CA) | 1997-04-01 | — | — | US | disclosed |
| EP-0731841-A1 | PROTEASES FROM STREPTOMYCES AND USE THEREOF IN PROTEIN EXPRESSION SYSTEMS | Cangene Corporation (CA) | 1996-09-18 | — | — | EP | disclosed |
| EP-0720657-A1 | BIOLOGICALLY RELEVANT METHODS FOR THE RAPID DETERMINATION OF STERILITY | NORTH AMERICAN SCIENCE ASSOCIATES INCORPORATED (US) | 1996-07-10 | — | — | EP | disclosed |
| US-5486459-A | Biologically relevant methods for the rapid determination of sterility | MEDICAL COLLEGE OF OHIO (US) | 1996-01-23 | — | — | US | disclosed |
| WO-1995017512-A2 | PROTEASES FROM STREPTOMYCES AND USE THEREOF IN PROTEIN EXPRESSION SYSTEMS | CANGENE CORPORATION (CA) | 1995-06-29 | — | — | WO | disclosed |
| WO-1995008639-A1 | BIOLOGICALLY RELEVANT METHODS FOR THE RAPID DETERMINATION OF STERILITY | NORTH AMERICAN SCIENCE ASSOCIATES, INC. (US) | 1995-03-30 | — | — | WO | disclosed |
| US-5159060-A | Cytotoxic boronic acid peptide analogs | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 1992-10-27 | — | — | US | disclosed |
| US-5106948-A | Anticarcinogenic agents | MAO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 1992-04-21 | — | — | US | disclosed |
| US-4963655-A | ANTITUMOR AGENTS; VIRICIDES, AIDS, HERPES; ANTICANCER AGENTS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 1990-10-16 | — | — | US | disclosed |